N Blais1, M Bouchard2, M Chinas3, H Lizotte4, M Morneau5, J Spicer6, S Martel7. 1. Service d'hémato-oncologie, Département de médecine, Centre hospitalier de l'Université de Montréal, Montreal, QC. 2. Service de radio-oncologie, Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC. 3. Programme québécois de cancérologie, Ministère de la Santé et des Services sociaux du Québec, Quebec City, QC. 4. Direction générale, Institut universitaire de cardiologie et pneumologie de Québec, Quebec City, QC. 5. Direction de l'offre de soins et services en cancérologie, Programme québécois de cancérologie, Ministère de la Santé et des Services sociaux du Québec, Quebec City, QC. 6. Division of Thoracic and Upper Gastrointestinal Surgery, Department of Surgery, McGill University, McGill University Health Centre, Montreal, QC. 7. Service de pneumologie, Institut universitaire de cardiologie et pneumologie de Québec, Quebec City, QC.
Abstract
Background: The emergence of covid-19 has the potential to change the way in which the health care system can accommodate various patient populations and might affect patients with non-covid-19 problems. The Quebec Lung Cancer Network, which oversees thoracic oncology services in the province of Quebec under the direction of the Ministère de la Santé et des Services sociaux, convened to develop recommendations to deal with the potential disruption of services in thoracic oncology in the province of Quebec. The summary provided here has been adapted from the original document posted on the Programme québécois du cancer Web site at: https://www.msss.gouv.qc.ca/professionnels/documents/coronavirus-2019-ncov/PJ1_Recommandations_oncologie-thoracique-200415.pdf. Methods: Plans to optimize the health care system and potentially to prioritize services were discussed with respect to various levels of activity. For each level-of-activity scenario, suggestions were made for the services and treatments to prioritize and for those that might have to be postponed, as well as for potential alternatives to care. Results: The principal recommendation is that the cancer centre executive committee and the multidisciplinary tumour board always try to find a solution to maintain standard-of-care therapy for all patients with thoracic tumours, using novel approaches to treatment and the adoption of a network approach to care, as needed. Conclusions: The effect of the covid-19 pandemic on the health care system remains unpredictable and requires that cancer teams unite and offer the most efficient and innovative therapies to all patients under the various conditions that might be forced upon them. 2020 Multimed Inc.
Background: The emergence of covid-19 has the potential to change the way in which the health care system can accommodate various patient populations and might affect patients with non-covid-19 problems. The Quebec Lung Cancer Network, which oversees thoracic oncology services in the province of Quebec under the direction of the Ministère de la Santé et des Services sociaux, convened to develop recommendations to deal with the potential disruption of services in thoracic oncology in the province of Quebec. The summary provided here has been adapted from the original document posted on the Programme québécois du cancer Web site at: https://www.msss.gouv.qc.ca/professionnels/documents/coronavirus-2019-ncov/PJ1_Recommandations_oncologie-thoracique-200415.pdf. Methods: Plans to optimize the health care system and potentially to prioritize services were discussed with respect to various levels of activity. For each level-of-activity scenario, suggestions were made for the services and treatments to prioritize and for those that might have to be postponed, as well as for potential alternatives to care. Results: The principal recommendation is that the cancer centre executive committee and the multidisciplinary tumour board always try to find a solution to maintain standard-of-care therapy for all patients with thoracic tumours, using novel approaches to treatment and the adoption of a network approach to care, as needed. Conclusions: The effect of the covid-19 pandemic on the health care system remains unpredictable and requires that cancer teams unite and offer the most efficient and innovative therapies to all patients under the various conditions that might be forced upon them. 2020 Multimed Inc.
Authors: Jean-Pierre Pignon; Hélène Tribodet; Giorgio V Scagliotti; Jean-Yves Douillard; Frances A Shepherd; Richard J Stephens; Ariane Dunant; Valter Torri; Rafael Rosell; Lesley Seymour; Stephen G Spiro; Estelle Rolland; Roldano Fossati; Delphine Aubert; Keyue Ding; David Waller; Thierry Le Chevalier Journal: J Clin Oncol Date: 2008-05-27 Impact factor: 44.544
Authors: Mariano Provencio; José María Mazarico Gallego; Antonio Calles; Mónica Antoñanzas; Cristina Pangua; Xabier Mielgo Rubio; Ernest Nadal; Rafael López Castro; Ana López-Martín; Edel Del Barco; Manuel Dómine; Fernando Franco; Pilar Diz; Carmen Sandoval; Elia Sais Girona; Ivana Sullivan; Mª Ángeles Sala; Gema García Ledo; Marc Cucurull; Joaquín Mosquera; Mireia Martínez; Luis Enrique Chara; Edurne Arriola; Beatriz Esteban Herrera; José Ramón Jarabo; Rosa Álvarez Álvarez; Javier Baena; María González Cao Journal: Lung Cancer Date: 2021-05-14 Impact factor: 5.705
Authors: Roy A Hilzenrat; Shaun A Deen; John Yee; Kyle A Grant; Ahmad S Ashrafi; Shaun Coughlin; Anna L McGuire Journal: Curr Oncol Date: 2021-02-18 Impact factor: 3.677